Skip to content

NRX Pharmaceuticals, Inc.

NRXP Nasdaq SEC CIK 1719406

Follow NRX Pharmaceuticals Weekly email: filings, results, news

News

3 stories filed under NRX Pharmaceuticals, grouped into ongoing threads

Ketamine

Thread · 2 stories

NRX Pharmaceuticals Inc (NRXP) (Q2 2026) Earnings Call Highlights: Advancing Ketamine Pipeline ...

Earnings 37 d ago 2 sources

NRx Pharmaceuticals, Inc. (NRXP) Discusses FDA First Cycle Review Outcome and Commercialization Plans for Preservative Free Ketamine Transcript

Markets 45 d ago

More coverage

H.C. Wainwright reiterates Buy on NRx Pharmaceuticals stock at $45

Markets 29 d ago

Profile

Headquarters: WILMINGTON, DE, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Latest filings

Q2 2026 report10-Q · 14 Aug 2026

Peers

Where this page comes from

Profile · SEC EDGAR

Financials · SEC EDGAR filing dates

News · 3 stories clustered from the RSS aggregator